Rosenberg Martin 4
4 · CUBIST PHARMACEUTICALS INC · Filed Oct 2, 2012
Insider Transaction Report
Form 4
Rosenberg Martin
Director
Transactions
- Exercise/Conversion
Common Stock
2012-10-01$22.71/sh+10,000$227,100→ 14,658 total - Sale
Common Stock
2012-10-01$47.75/sh−10,000$477,475→ 4,658 total - Exercise/Conversion
Stock Options (Right to Buy)
2012-10-01−10,000→ 0 totalExercise: $22.71From: 2007-06-08Exp: 2016-06-08→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]Sold pursuant to a Rule 10(b)5-1 Plan
- [F2]This transaction was executed in multiple trades at prices ranging from $47.55 to $48.02. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Option vests 100% on one-year anniversary of grant.